Joseph K. Belanoff Salary and Compensation - CORCEPT THERAPEUTICS INC CEO Pay 2025

In fiscal year 2025, Joseph K. Belanoff, M.D., of CORCEPT THERAPEUTICS INC (CORT), received total compensation of $15.3 million.

Joseph K. Belanoff's compensation breakdown includes: base salary of $1.2 million, bonus of $1.2 million, option awards of $12.9 million, and other compensation of $24K.

Compared to fiscal year 2024, Joseph K. Belanoff's total compensation increased 55% from $9.9 million to $15.3 million.

CORCEPT THERAPEUTICS INC (CORT) Executive Pay 2025

CORCEPT THERAPEUTICS INC's top 5 named executive officers received combined total compensation of $40.4 million in fiscal year 2025.

The named executive officers disclosed in CORCEPT THERAPEUTICS INC's 2025 proxy statement are:Joseph K. Belanoff (M.D.,) with total compensation of $15.3 million, Charles Robb (Chief Business Officer and) with total compensation of $6.4 million, William Guyer (Pharm.D.,) with total compensation of $6.3 million, Sean Maduck (President) with total compensation of $6.2 million, and Atabak Mokari (Chief Financial Officer and) with total compensation of $6.1 million.